Back to
U.S. Bancorp
ARCT
30 quarters
Position history for
U.S. Bancorp's holdings in Arcturus Therapeutics Holdings Inc.
Yes. U.S. Bancorp holds 1,056 shares of ARCT (Arcturus Therapeutics Holdings), worth $14,457, as of its Q3 2026 13F filing. It increased the position by 633 shares (+149.7%) from Q2 2026. U.S. Bancorp has held ARCT since Q2 2019, across 30 quarterly 13F filings.
Current Value
$14,457
Current Shares
1,056
Total Value Change
+$8,457
Total Shares Change
+431
Quarter-by-Quarter History
Other major holders of ARCT: ARK Investment Management LLC, Federated Hermes, Inc.